Global Medical REIT (GMRE) Stock Price, News & Analysis

Company Overview

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities. Global Medical REIT’s portfolio spans major metropolitan areas as well as secondary and tertiary markets, with properties often located adjacent to or on the campuses of leading hospital systems. This geographic diversification supports tenant demand and reduces exposure to any single market.

Global Medical REIT’s tenants include hospitals, health systems, physician groups and post-acute care providers, reflecting a mix of credit profiles and lease terms. By partnering with established healthcare operators, the trust aims to benefit from the secular shift toward outpatient care and continued investment in facility upgrades. The company’s asset management team actively pursues value-add opportunities, including re-tenanting, redevelopments and operational enhancements.

Headquartered in New York City, Global Medical REIT is led by President and Chief Executive Officer Vadim Taube, whose team brings experience in real estate acquisition, healthcare operations and capital markets. The company’s governance framework and strategic focus on mission-critical healthcare properties underpin its objective of delivering predictable income and long-term shareholder value.

Key Stats

• Today's Range: $31.49 to $32.86
• 50-Day Range: $30.56 to $38.70
• 52-Week Range: $30.09 to $48.13
• Volume: 102,150 shs
• Average Volume: 142,096 shs
• Market Capitalization: $436.92 million
• P/E Ratio: 93.43
• Dividend Yield: 9.19%
• Price Target: $45.75
• Consensus Rating: Moderate Buy

Global Medical REIT Stock Analysis - MarketRank™

Global Medical REIT scored higher than 99% of companies evaluated by MarketBeat, and ranked 38th out of 940 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Global Medical REIT has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 4 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

Global Medical REIT has a consensus price target of $45.75, representing about 45.2% upside from its current price of $31.50.

Amount of Analyst Coverage

Global Medical REIT has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 3.70%

Earnings Growth

Earnings for Global Medical REIT are expected to grow by 3.70% in the coming year, from $0.81 to $0.84 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Global Medical REIT is 90.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 232.78.

Price to Earnings Ratio vs. Sector

The P/E ratio of Global Medical REIT is 90.01, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 29.93.

Price to Book Value per Share Ratio

Global Medical REIT has a P/B Ratio of 0.88. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.34% of the outstanding shares of Global Medical REIT have been sold short.

Short Interest Ratio / Days to Cover

Global Medical REIT has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Global Medical REIT has recently decreased by 79.18%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Global Medical REIT is a leading dividend payer. It pays a dividend yield of 9.59%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Global Medical REIT does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Global Medical REIT is 857.14%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on EPS estimates, Global Medical REIT will have a dividend payout ratio of 357.14% in the coming year. This indicates that Global Medical REIT may not be able to sustain their current dividend.

Sustainability and ESG

• Score: 3.6 / 5
• Environmental Score: -3.19

Percentage of Shares Shorted

4.34% of the outstanding shares of Global Medical REIT have been sold short.

Short Interest Ratio / Days to Cover

Global Medical REIT has a short interest ratio ("days to cover") of 3.4, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Global Medical REIT has recently decreased by 79.18%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 0.47

News Sentiment

Global Medical REIT has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.77 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for Global Medical REIT this week, compared to 3 articles on an average week.

Search Interest

21 people have searched for GMRE on MarketBeat in the last 30 days. This is an increase of 425% compared to the previous 30 days.

MarketBeat Follows

4 people have added Global Medical REIT to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Global Medical REIT insiders have bought more of their company's stock than they have sold. Specifically, they have bought $9,963.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 8.50% of the stock of Global Medical REIT is held by insiders.

Percentage Held by Institutions

57.52% of the stock of Global Medical REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

GMRE Stock Analysis - Frequently Asked Questions

How have GMRE shares performed this year?

Global Medical REIT's stock was trading at $38.60 at the beginning of 2025. Since then, GMRE shares have decreased by 18.4% and is now trading at $31.5020.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc. (NYSE:GMRE) issued its earnings results on Tuesday, August, 5th. The company reported $1.15 EPS for the quarter, hitting the consensus estimate of $1.15. The company had revenue of $37.88 million for the quarter, compared to analysts' expectations of $35.57 million. Global Medical REIT had a net margin of 7.32% and a trailing twelve-month return on equity of 2.21%.
Read the conference call transcript.

When did Global Medical REIT's stock split?

Global Medical REIT shares reverse split on Monday, September 22nd 2025.A 1-5 reverse split was announced. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, September 21st 2025. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Is Global Medical REIT buying back stock?

Global Medical REIT's Board of Directors approved a stock buyback plan on Wednesday, August 13th 2025, which authorizes the company to repurchase $50,000,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 11.1% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's board believes its shares are undervalued.

When did Global Medical REIT IPO?

Global Medical REIT (GMRE) raised $130 million in an initial public offering on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

How do I buy shares of Global Medical REIT?

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Global Medical REIT investors own include American Water Works (AWK), DiamondRock Hospitality (DRH), AUO (AUOTY), The RMR Group (RMR), Waste Connections (WCN), Voyager Therapeutics (VYGR) and Humana (HUM).

Company Calendar

• Last Earnings: 8/05/2025
• Record date for 10/15 Dividend: 9/29/2025
• Ex-Dividend for 10/15 Dividend: 9/29/2025
• Today: 10/15/2025
• Dividend Payable: 10/15/2025
• Next Earnings (Estimated): 11/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: REIT - EQTY TRUST - OTHER
• Sub-Industry: Trading
• Current Symbol: NYSE:GMRE
• CIK: 1533615
• Web: www.globalmedicalreit.com
• Phone: (202) 524-6851
• Fax: N/A
• Employees: 30
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Global Medical REIT: $45.75
• High Price Target: $58.75
• Low Price Target: $40.00
• Potential Upside/Downside: +42.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 8 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.35
• Trailing P/E Ratio: 91.92
• Forward P/E Ratio: 39.74
• P/E Growth: N/A
• Net Income: $6.63 million
• Net Margins: 7.32%
• Pretax Margin: 7.50%
• Return on Equity: 2.21%
• Return on Assets: 0.82%

Debt

• Debt-to-Equity Ratio: 1.56
• Current Ratio: 0.28
• Quick Ratio: 0.28

Sales & Book Value

• Annual Sales: $138.78 million
• Price / Sales: 3.10
• Cash Flow: $5.00 per share
• Price / Cash Flow: 6.44
• Book Value: $36.00 per share
• Price / Book: 0.89

Miscellaneous

• Outstanding Shares: 13,380,000
• Free Float: 12,239,000
• Market Cap: $430.70 million
• Optionable: Optionable
• Beta: 1.19